Such a dual action may proof very effective to intervene in chronic inflammatory diseases and the potential use for MIF neutralizing or antagonizing strategies specifically in T1D and potentially also other inflammatory disorders, warrants further investigation. The gene discussed is MIF; the disease is type 1 diabetes mellitus.